Fanconi Anemia patients from an indigenous community in Mexico Carry a new founder pathogenic variant in FANCG
This is actually super cool
As generic versions approach regulatory approval and Novo Nordisk prepares competitive, lower-priced alternatives, patients should see significantly improved affordability by late 2026 or early 2027
At least a dozen similar experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing
Zur Nomenklatur ist anzumerken, dass die deutsche Bezeichnung ohne -e am Ende des Wirkstoffnamens geschrieben wird
However, due to COVID-19 restrictions, we have not been able to carry out experiments to test the glutathione system Survival Assay To perform the survival assay, E